Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H, Waga K, Nakamura F, Maki K, Sasaki K, Nakamura Y, Mitani K. Gunji H, et al. Among authors: waga k. Biochem Biophys Res Commun. 2004 Sep 17;322(2):623-30. doi: 10.1016/j.bbrc.2004.07.169. Biochem Biophys Res Commun. 2004. PMID: 15325275
Functional regulation of TEL by p38-induced phosphorylation.
Arai H, Maki K, Waga K, Sasaki K, Nakamura Y, Imai Y, Kurokawa M, Hirai H, Mitani K. Arai H, et al. Among authors: waga k. Biochem Biophys Res Commun. 2002 Nov 22;299(1):116-25. doi: 10.1016/s0006-291x(02)02588-3. Biochem Biophys Res Commun. 2002. PMID: 12435397
Functional analysis of a dominant-negative DeltaETS TEL/ETV6 isoform.
Sasaki K, Nakamura Y, Maki K, Waga K, Nakamura F, Arai H, Imai Y, Hirai H, Mitani K. Sasaki K, et al. Among authors: waga k. Biochem Biophys Res Commun. 2004 May 14;317(4):1128-37. doi: 10.1016/j.bbrc.2004.03.172. Biochem Biophys Res Commun. 2004. PMID: 15094386
[Myeloperoxidase].
Nakamura Y, Waga K, Mitani K. Nakamura Y, et al. Among authors: waga k. Nihon Rinsho. 2004 Dec;62 Suppl 12:781-4. Nihon Rinsho. 2004. PMID: 15658449 Review. Japanese. No abstract available.
[Neutrophil alkaline phosphatase score].
Nakamura Y, Waga K, Mitani K. Nakamura Y, et al. Among authors: waga k. Nihon Rinsho. 2004 Dec;62 Suppl 12:785-8. Nihon Rinsho. 2004. PMID: 15658450 Review. Japanese. No abstract available.
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.
Saito K, Nakamura Y, Aoyagi M, Waga K, Yamamoto K, Aoyagi A, Inoue F, Nakamura Y, Arai Y, Tadokoro J, Handa T, Tsurumi S, Arai H, Kawagoe Y, Gunnji H, Kitsukawa Y, Takahashi W, Furusawa S. Saito K, et al. Among authors: waga k. Int J Hematol. 2000 Apr;71(3):238-44. Int J Hematol. 2000. PMID: 10846828
22 results